NOVACYT Aktie
0,53EUR | -0,01EUR | -1,85% |
WKN DE: A12CFH / ISIN: FR0010397232
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 229 | 189 | 143 | 72 | 48 |
Summe Anlagevermögen | 33 | 30 | 15 | 83 | 38 |
Summe Aktiva | 262 | 219 | 159 | 154 | 85 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 93 | 50 | 29 | 54 | 28 |
Summe Eigenkapital | 168 | 169 | 130 | 101 | 58 |
Summe Passiva | 262 | 219 | 159 | 154 | 85 |
Adresse
131 Boulevard Carnot, 78110 Le Vésinet | |
Telefon | +33 (1) 39-46-51-04 |
Fax | +33 (1) 30-70-05-32 |
Internet | http://www.novacyt.com |
Management
Ian David Gilham
Non-Executive Director |
Jean-Pierre Crinelli
Independent Non-Executive Director |
Joanne Nicola Mason
Chief Scientific Officer & Executive Director |
John Robert Brown
Chairman |
Juliet Thompson
Independent Non-Executive Director |
Lyn Dafydd Rees
Chief Executive Officer & Executive Director |
Mandy Cowling
Manager-Corporate & Investor Relations |
Steven Michael Gibson
Chief Financial Officer & Executive Director |